GW researchers successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection, affecting more than a quarter of a billion people in Southeast Asia, sub-Saharan Africa, and Latin America
For the first time, researchers at the George Washington University (GW), together with colleagues at institutes in Thailand, Australia, the U.K. and the Netherlands, and more, have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for schistosomiasis and for liver fluke infection, which can cause a diverse spectrum of human disease including bile duct cancer. Their findings are found in two papers published today in the journal eLife.
“The genes we ‘knocked out’ using CRISPR/Cas9 resulted in markedly diminished symptoms of infection in our animal models,” said Paul Brindley, PhD, professor of microbiology, immunology, and tropical medicine at the GW School of Medicine and Health Sciences, and lead author. “Our research also showed that this revolutionary new biomedical procedure — CRISPR/Cas9 — can be adapted to study helminth parasites, which are a major public health problem in tropical climates.”
CRISPR/Cas9 is a new technology that allows researchers to precisely target and deactivate the genetic information needed to produce a particular protein. While the tool has been used in other species before, it was unknown if it could be applied to Schistosoma mansoni and Opisthorchis viverrini, the parasites responsible for schistosomiasis and liver fluke infection.
Schistosomiasis can cause serious health problems, including damage to the liver and kidneys, infertility and bladder cancer. The freshwater worms S. mansoni enter the human body by burrowing into the skin; once in the bloodstream, they move to various organs where they rapidly start to reproduce. Their eggs release several molecules, including a protein known as omega-1 ribonuclease, which can damage the surrounding tissues. Brindley and his research team “knocked out” this protein using CRISPR/Cas9 and found that it greatly reduced the impact of the disease.
Liver fluke infection can cause a type of liver cancer called bile duct cancer, triggered by the presence of the worm O. viverrini. This parasite is transmitted through traditional Southeast Asian cuisines using uncooked or undercooked fish. Once inside the body, the parasite settles in the human liver and secretes a protein known as granulin that may encourage liver cells to multiply, raising the risk for cancer. Brindley and his research team used CRISPR/Cas9 to deactivate the gene that codes for granulin and create parasites that can only produce very little of the protein, leading to markedly reduced symptoms of liver fluke infection.
“These neglected tropical diseases affect more than a quarter of a billion people primarily living in Southeast Asia, sub-Saharan Africa, and Latin America,” said Brindley. “CRISPR/Cas9 is a tool that may be used to limit the impact of these infections. As we work to better understand how these parasites invade and damage our bodies through this new technology, we will find new ideas for treatment and disease control.”
The Latest on: CRISPR/Cas9
via Google News
The Latest on: CRISPR/Cas9
- Researcher expands plant genome editing with newly engineered variant of CRISPR-Cas9on January 22, 2021 at 9:46 am
Alongside Dennis van Engelsdorp, associate professor at the University of Maryland (UMD) in Entomology named for the fifth year in a row for his work in honey bee and pollinator health, Yiping Qi, ...
- Plant genome editing expanded with newly engineered variant of CRISPR-Cas9on January 20, 2021 at 4:00 pm
Scientists have created a newly engineered variant of the famed gene editing tool CRISPR-Cas9. SpRY removes the barriers of what can and can't be targeted for gene editing, making it possible for the ...
- Natural CRISPR’s Safety Feature Could Become Genetic Dimmer Switchon January 19, 2021 at 2:45 pm
Cas9 systems avoid causing autoimmunity in bacteria when they complex with a natural single-guide RNA that is a long-form tracrRNA that targets a Cas9 promoter.
- Gene-cutting system may play second role as a genetic dimmer switchon January 19, 2021 at 7:54 am
In a series of experiments with laboratory-cultured bacteria, Johns Hopkins scientists have found evidence that there is a second role for the widely used gene-cutting system CRISPR-Cas9 -- as a ...
- CRISPR technology shown to dial down gene activity in bacteriaon January 19, 2021 at 7:31 am
In a series of experiments with laboratory-cultured bacteria, Johns Hopkins scientists have found evidence that there is a second role for the widely used gene-cutting system CRISPR-Cas9—as a genetic ...
- Gene-editing 'scissor' tool may also be a 'dimmer switch'on January 19, 2021 at 6:01 am
The CRISPR-Cas9 system in the Johns Hopkins study is more widely used by scientists as a gene-cutting tool, and the Johns Hopkins team's findings provide evidence that the dimmer action controls ...
- TOP delivery of CRISPR-Cas9 machinery to primary T cellson January 18, 2021 at 10:44 am
The last 10 years have witnessed the remarkable advancement of CRISPR-Cas9 technology from discovery to early development to its clinical application to treat various diseases. However, CRISPR-Cas9 ...
- 7 CRISPR Stocks for the Future of Medicineon January 15, 2021 at 3:12 pm
Doudna and Charpentier noted a naturally occurring genome editing system in bacteria, wherein bacteria capture snippets of DNA from invading viruses and create new DNA segments called CRISPR arrays ...
- One step closer to CRISPR-Cas9 cancer therapieson January 15, 2021 at 5:16 am
Cas9 cancer therapies. Once CRISPR-Cas9 genome editing technology became available, scientists worldwide began using it to learn more ab ...
- Detecting CRISPR-Cas9 Gene Doping in Athleteson January 13, 2021 at 11:28 am
Cas9 could allow persons to manipulate babies by changing their eye color or hair color, for example. Now, German researchers have extrapolated that situation further—what if athletes are tempted to ...
via Bing News